Regenicin Inc Share Price OTC Bulletin Board
Equities
US75887Q1022
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2021 | - | Sales 2022 | - | Capitalization | 491K 38.73M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net Debt 2021 | 598K 47.18M | Net Debt 2022 | 627K 49.47M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2
x | P/E ratio 2022 |
-0.71
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 79.1% |
Managers | Title | Age | Since |
---|---|---|---|
Randall McCoy
CEO | Chief Executive Officer | 74 | 14/07/10 |
John Weber
DFI | Director of Finance/CFO | 74 | 12/09/10 |
J. Nelson
CTO | Chief Tech/Sci/R&D Officer | 75 | 14/07/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Weber
DFI | Director of Finance/CFO | 74 | 12/09/10 |
Randall McCoy
CEO | Chief Executive Officer | 74 | 14/07/10 |
1st Jan change | Capi. | |
---|---|---|
+16.45% | 122B | |
+21.96% | 116B | |
+23.73% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-16.52% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |